Immunome Inc. Operating Lease, Liability
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability $4.74M.
- 2026-03-31: Operating Lease, Liability $3.69M.
- 2025-12-31: Operating Lease, Liability $3.85M.
- 2025-09-30: Operating Lease, Liability $4.01M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $4.74M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $3.69M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $3.85M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $4.01M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.14M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $4.77M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $4.83M 10-K · filed 2025-03-19 | |
| 2024-09-30 | $2.72M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.77M 10-Q · filed 2024-08-12 | |
| 2022-01-01 | $500.00K 10-K · filed 2023-03-16 | $200.00K 10-Q · filed 2022-05-12 |